A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

By Sedlis A.   Bundy B.N.   Rotman M.Z.   Lentz S.S.   Muderspach L.I.   Zaino R.J.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Muderspach L.I.   Blessing J.A.   Levenback C.   Moore J.L.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 213-215

Elsevier

Access to resources Recommend Favorite

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

By Schilder R.J.   Blessing J.A.   Morgan M.   Mangan C.E.   Rader J.S.  

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 204-207

Elsevier

Access to resources Recommend Favorite

Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)

By                        

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 487-493

Spandidos Publications

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M.   Blessing J.A.   Wolf J.   Rocereto T.F.   Berek J.S.   Waggoner S.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite